相关实验视频
Updated: Jun 12, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
心脏病儿童干预心脏病的最新情况
Kamel Shibbani1, Damien Kenny2
1University of Iowa Children's Hospital, Iowa, USA. kshibbani@uiowa.edu.
European journal of pediatrics
|June 7, 2025
概括
儿科干预心脏病学正在推进新的设备和程序. 登记册和多中心研究对于标准化护理和改善先天性心脏病的治疗结果至关重要.
科学领域:
- 儿科干预心脏病学
- 遗传性心脏病是一种先天性心脏病.
- 过导管干预措施 过导管干预措施
背景情况:
- 对于先天性心脏病的透导管手术越来越复杂.
- 在当前的儿科干预心脏病实践中存在显著的变化.
- 新型设备,包括自扩张的肺门和可生物吸收的支架,正在开发中.
研究的目的:
- 审查儿科干预心脏病学的新兴程序和设备.
- 介绍关于尖端跨导管干预的临床数据.
- 讨论讨论的领域,并提出未来的研究方向.
主要方法:
- 对儿科干预心脏病学的最新创新进行了回顾.
- 从注册表和多中心研究中分析数据.
- 讨论正在进行的辩论和未来的研究需求.
主要成果:
- 创新包括专利通道动脉关闭,扩大肺替换选项和通道支架.
- 新型儿科专用设备的开发正在进行中.
- 登记册和多中心研究可以为管理提供基于证据的见解.
结论:
- 需要标准化指导方针来解决儿科干预心脏病学的变异性.
- 新兴的程序和设备显示出改善先天性心脏病治疗的希望.
- 进一步的研究对于完善和标准化实践至关重要.
相关概念视频
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy II: Dilated Cardiomyopathy
1
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
1
Heart Failure VI: Adjunct Therapies
5
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
5
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1

